Demand for the stock from multiple parties is pushing the price higher; it could be that word is getting out about its virtues as a business. During this time, he continued his academic research as part of an international circle of collaborators. Ms Saini is expert in breast cancer, breast density and breast cancer risk assessment. Reports ... At the current share price of $1.44, The market cap is A$360 million which gives a Price to Sales of ~ 13.7 (After converting ARR to AUD). The acquisition price is US$18 million, with a further US$4 million payable on meeting key performance and staff retention targets. Past performance is not necessarily indicative of future returns.
jQuery('html, body').animate({ She served as a Senior VP, Legal Affairs, General Counsel, Corporate Secretary, Chief Compliance Officer, Chief Privacy Officer, and Chief Audit Executive at Availity, a revenue-cycle management, electronic data interchange platform, PaaS IT company that operates the real time information network in healthcare. 12 month transaction history compiled from ASX announcements. He has served on two Prime Ministers Science and Technology Councils and Advisory Boards, and was Deputy Chairman of the Australian Governments Export Agency, Austrade, from 1990 to 1997. Previously, he served as President and CEO of R2 Technology, Inc., computer assisted detection of breast cancer, until Hologic, Inc. acquired the company in 2006. The Volpara Health Technologies Ltd (ASX: VHT) share price has returned from its trading halt and is pushing higher on Tuesday. }); Investors Who Bought Volpara Health Technologies (ASX:VHT) Shares Three Years Ago Are Now Up 160%. Products Breast health Lung health Science News and Events News Blog Whitepapers Events Investors Investor overview Market announcements Share price Presentations … This constitutes a share price movement of 4.69% when compared to its closing share price of $1.28 seven days ago. For the period ending 31 March, Volpara experienced its largest ever quarterly sales performance. /*document.querySelectorAll('a[href^="#"]').forEach(anchor => { Subscription Terms of Service, ACN: 146 988 052 | Australian Financial Services Licence (AFSL): 400691, The Motley Fool Australia, PO Box 4635, Ashmore, Qld 4214, jQuery(document).on('click', 'a[href^="#"]', function (event) { The Motley Fool Australia does not guarantee the performance of, or returns on any investment. Volpara Health Technologies Ltd (ASX: VHT) Another small cap tech share … The healthcare technology company has been making tailwinds recently, reflecting a surge in its shares from March onwards. Volpara Health Technologies (ASX:VHT) Is Using Debt Safely By Simply Wall St Published December 24, 2020. the sale of VolparaEnterprise software, a comprehensive cloud-based breast imaging analytics platform that delivers quality assurance and performance monitoring. This indicates that VHT may be slightly undervalued compared with other SaaS companies. }, 500); In 1996 he cofounded Allen & Buckeridge, an early-stage venture capital fund with offices in Silicon Valley and Australia. As you can see below, at the end of September 2020, Volpara Health Technologies had NZ$2.62m of debt, up from none a year ago. She is Chair of the Risk Committee. The company's product consists of breast imaging analytics platform that delivers real-time quality assurance and performance monitoring. It’s worth noting that most of the ASX market is down from Wall Street losses overnight. Latest Share Price and Events. Volpara Health Technologies Limited (VHT) is a MedTech SaaS company and is a provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer. The Volpara Health Technologies Ltd (ASX: VHT) share price is rising this morning following the release of a trading update. HotCopper has news, discussion, prices and market data on VOLPARA HEALTH TECHNOLOGIES LIMITED. The business of the company operates through three product categories that include Capital Sales, Software Maintenance Agreement, and Software as a Service. it's usually once a year in their Annual Report. Data supplied by Morningstar and accurate on Jun 16, 2020. Latest financial information. being published and the data appearing on Market Index (<7 days for ASX 300 But it also has NZ$64.3m in cash to offset that, meaning it has NZ$61.7m net cash. Volpara’s software is used for screening clinics to provide feedback on breast density, compression, dose and quality. And the share price momentum remains respectable, with a gain of 39% in the last three months. At the time of writing, the Volpara share price is trading at $1.44, up 0.015%. He provides the possible measurements of breast composition (breast density) in order to improve the health outcomes of women around the world. Mr Reid brings commercial experience gained across a range of technology/ Software as a Service (SaaS) businesses. Market Index Pty Ltd (ACN: 600 705 155) is a Corporate Authorised Representative of Volpara Health Technologies has a market capitalization of $0.00 and generates $15.22 million in revenue each year. Share price Presentations Corporate governance FAQ Volpara About us ... (ASX:VHT). 10 Stocks To Buy (including 2 Every Investor Should Own), Setting Yourself Up for Success Before You Start. scrollTop: jQuery(jQuery.attr(this, 'href')).offset().top He held a number of key executive roles in businesses such as Air New Zealand, MetService, Carter Holt Harvey, and Ernst & Young. ASX:VHT Debt to Equity History March 25th 2021 The Volpara Health Technologies Ltd (ASX: VHT) share price is edging higher today. Please remember that investments can go up and down. Privacy Policy | Volpara Health Technologies Ltd shares are gaining today after the company released its quarterly results. Other key directorship roles include Christchurch International Airport Limited and Comvita Limted. event.preventDefault();
Click the image for more detail. April 20th, 2021 - Motley Fool How did Volpara perform? Whilst $400,000 a year doesn’t seem like much compared to Volpara’s current market cap, the company has a very high gross profit margin – so most of this new revenue will fall to the the profit lines of Volpara’s financials. Volpara has increased annual recurring revenue by more than 100x since listing on the Australian Securities Exchange in 2016. Discover the latest VHT:ASX share price news, today's movements and market info at The Market Herald – First with the news that moves markets. The Motley Fool Australia operates under AFSL 400691. In fact, VHT shares were a stock we got our clients into during September 2018, when the VHT share price was at around $0.80. Mr Allen is a experienced entrepreneur and investor in early stage growth companies in Australia, New Zealand and internationally. He was also named a Wellingtonian of the Year finalist. The Complete Guide to Planning For Your Retirement, Setting up an SMSF: 10 Things You Need to Know Before Starting, 3 easy steps to building your ASX share portfolio for an early retirement, 4 tips on how to pick winning stocks for your retirement share portfolio, This is the best asset to own to start saving for your early retirement, Commonwealth Bank of Australia (ASX: CBA), Flight Centre Travel Group Ltd (ASX: FLT), Vanguard Australian Shares Index (ASX: VAS), 2 rapidly growing small cap ASX shares to watch, 2 ASX tech shares that are growing rapidly, 2 quality SaaS ASX shares to buy in May 2021, Here’s why the Volpara (ASX:VHT) share price is up 6% today, Volpara (ASX:VHT) share price rising following Q4 business update, 3 growing small cap ASX tech shares to watch, Non-Executive Director,Non-Executive Chairman, Chief Executive Officer,Executive Director, Chief Financial Officer,Joint Company Secretary, Ralph Highnam And Kyc Trustees 106 Limiteddocument.querySelector(this.getAttribute('href')).scrollIntoView({ Volpara Health Technologies Stock Forecast, VHT stock price prediction. It's not possible to publish a real-time Top 20 Shareholder list. Join the HotCopper ASX share market forum today for free. Over the past 25 years he has managed the processes to raise capital, perform due diligence, and seek ASX listing for a number of enterprises, including IPOs for a range of offerings. How Much Money Do I Need To Start Investing? She undertook US radiology training and an additional fellowship in women's imaging, and has over 10 years of patient care experience in both private and public sectors. VHT's Principal Activity is software. What Is Volpara Health Technologies's Net Debt? View dividend history, insider trades and ASX analyst consensus. e.preventDefault();
Market … Companies are not obliged to report this data (with the exception of Substantial }); He has been awarded the two lifetime awards in the IT industry (CSIRO Tony Benson award and the Pearcey Medal for lifetime achievement), Chief Executive Officer,Executive Director. One of them is Volpara Health Technologies Ltd (ASX:VHT). She was a founding faculty member in the Health Informatics Master's Programs at both Northwestern University (Chicago), and University of Colorado (College of Nursing), and has taught in schools of medicine, law, and business at US universities. View presentation Interim Financial Report. Volpara Health Technologies Limited (VHT) Overview. © Provided by The Motley Fool medical asx share price represented by doctor giving thumbs up In early morning trade, the Volpara share price is up 1.3% to $1.50. Read detailed company information including current share prices, financial summary, directors, announcements, dividends & news. I think that the Volpara share price is definitely one to watch for the long term at the current level of $1.27. Previously an Adjunct Professor in the Business School of the University of Technology Sydney, he has also lectured at the School of Entrepreneurship at INSEAD. Mr Pavlidis has more than 30 years of medical device experience as a senior executive, CEO or company director in the areas of diagnostic imaging, women's health, image analysis and artificial intelligence, and cardiovascular therapies. In that capacity she worked globally on early detection of breast cancer, breast cancer research, and physician education for breast imaging technologies. Volpara Health Technologies (ASX:VHT) Shareholders Booked A 93% Gain In The Last Three Years By Simply Wall St Published January 28, 2021. Mr Diddams has knowledge and practical experience in the application of Australian corporations law, ASX Listing Rules, international accounting standards, and corporate governance principles. Quarterly results 2021 Investor Webcast . This Service provides only general, and not personalised financial advice, and has not taken your personal circumstances into account. Under his leadership Mirada became the number one provider of image registration and fusion tools before being acquired by CTI Molecular Imaging Inc. and later Siemens Medical Solutions USA, Inc. Sign in. Management clearly think so, as does the market – that’s why the share price went up so much today. Her previous roles include General Counsel, Chief Compliance Officer & Chief Privacy Officer at the University HealthSystem Consortium, General Counsel & Chief Privacy Officer at ReedGroup, a data and informatics technology company. You must be logged in to access this feature. These include oil and gas interests, food and retail, a fine wool processing plant, an telephony product, a biotech company, an Internet advertising initiative, a dental device for snoring and sleep apnoea, an indoor skydiving company, the New Zealand developer of the Martin Jetpack, a healthy fast food chain, and Skydive the Beach Group Limited (now Experience Co Limited). Stable Share Price: VHT is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 6% a week. ASX companies. Share price Presentations Corporate governance FAQ Volpara About us ... Find important Volpara Health (ASX:VHT) investor information, including market releases, announcements, reports and updates. Each company boasts strong growth prospects over the next 3 to 5 years, and most importantly each pays a generous (and fully franked) dividend! The Volpara Health Technologies Ltd ( ASX: VHT) share price could rise today after an impressive FY21 third quarter update. Please also refer to our pages on ASX for more information and the current share price for Volpara Health. Everything You Need to Know About Tech Investing. No sell transactions reported by Substantial Shareholders in the past 12 months. He consulted medical imaging companies which includes R2, Siemens, Hologic, and Dexela, as well as breast screening programs. Relative to today's opening stock price, the VHT stock price is down $0.01 or -0.74%. When all “Last Notice” dates are identical, it suggests that no (or minimal) change Shareholding changes less than 1% do not require notification to the market. Until recently, he served as the President and CEO of Vytronus, Inc., a venture backed startup using novel catheterbased ultrasound and robotics technology to treat atrial fibrillation, a cardiac arrhythmia. All data on this page is supplied by the ASX, Morningstar and Market Index. At that level they are trading at 40.09% discount to the analyst consensus target price of 0.00. What happened with the Volpara share price? Volpara Health Technologies Limited's current share price is $1.34. An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Shareholders above 5%). VHT directors must report any change in shareholding to the ASX within 5 business days. View webcast Half-year results 2021 Investor Presentation. anchor.addEventListener('click', function (e) { Volpara (ASX:VHT) share price rising following Q4 business update. No buy transactions reported by Substantial Shareholders in the past 12 months. For example, the Volpara Health Technologies Limited share price is up 93% in the … But many of us dare to dream of bigger returns, and build a portfolio ourselves. The VHT share price last traded at about $1.40, a … behavior: 'smooth' Up to 20 years of EOD share price history. A substantial shareholder is a person or entity that owns 5% or more of Volpara Health Technologies sells its product under the name of VolparaDensity, VolparaDose, VolparaServer, and VolparaAnalytics. Volpara said that CRA is profitable and has positive operating cashflow, based on financial results to 31 December 2020. Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know worries about.' As reported in the most recent Annual Report. Our Top 5 Stocks for Investors 50 or Older – NOW AVAILABLE! He is a Non-Executive Director of Aroa Biosurgery Limited, a New Zealand based company that develops and markets proprietary soft tissue regenerative products, and Surf Lakes Holdings Limited, a Gold Coast based business with patented technology for recreational wave generation. to not meeting QA guidelines. This comes after the company reported its trading update for the third-quarter of the 2021 financial year. Read the See Director Transactions for all ASX Prior R2 Technology, he was president of the global Ultrasound business at Siemens Healthcare. Earlier this month, Morgan Stanley put an overweight rating and $1.50 price target on the company’s shares. Share Price & News. Terms of Service | Prior to Vytronus, he was the President and CEO of Endoscopic Technologies, Inc., until it was acquired by AtriCure, Inc. in 2014. Find out more at Intelligent Investor }); Volpara shares are on the move today after the company provided investors with a business update for Q4 FY21. Dr Highnam has been in the digital breast imaging field for over 25 years. the voting shares in a company. In 2015, she became a medical advisor for GE Healthcare and in 2016 was appointed the company's medical director of automated breast ultrasound systems. Join the HotCopper ASX share market forum today for free.